| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Department of Biology, Sinsheimer Laboratories (G.T., G.O.G., B.N., F.T.), University of California, Santa Cruz, California 95064; Lawrence Berkeley Laboratory (S.G.), University of California, Berkeley, California 94720; and Morehouse School of Medicine, Department of Physiology (R.S.), Atlanta, Georgia 30310
Address all correspondence and requests for reprints to: Frank Talamantes, Department of Biology, Sinsheimer Laboratories, University of California, Santa Cruz, California 95064. E-mail: prolactin{at}aol.com
Pituitary hormones are essential for the maintenance of the corpus luteum in the pregnant mouse during the first half of gestation. Thereafter, hormones from the placenta take over the luteotropic role of the pituitary hormones. Mouse placental lactogen-I (mPL-I) and mPL-II, two PRL-like hormones produced in the placenta, are probably necessary for the maintenance of the corpus luteum in the latter half of pregnancy. A culture system of luteal cells from pregnant mice was developed to investigate the role of hormones from the placenta that may be important for the function of the corpus luteum. Mice were killed on days 10, 14, and 18 of pregnancy, and the corpora lutea were excised from the ovaries and digested in 0.1% collagenase, 0.002% DNase for 1 h. The resulting luteal cell suspension was plated onto 96-well plates coated with fibronectin (1 x 105 cells/well) and cultured for 1–3 days. Medium was changed daily. The cells were treated with various concentrations and combinations of mPL-I, mPL-II, mouse PRL, androstenedione, dihydrotestosterone, 17ß-estradiol (E2), testosterone, hydroxyflutamide, cycloheximide, actinomycin D, and fadrozole to study the effects of these different treatments on progesterone (P4) production. The three lactogens (mPL-I, mPL-II, and mouse PRL) all stimulated the release of P4 from the luteal cells. The potency of the lactogens was similar and did not depend on the stage of pregnancy at which the luteal tissue was obtained. However, the responsiveness of the cells to all hormone-stimulated P4 release was gradually reduced the later in pregnancy the tissue was collected. Androgens also stimulated the release of P4 from the luteal cells, and when administered together, the lactogens and the androgens acted synergistically to stimulate P4 release. The androgens acted directly but not through conversion to E2, as determined by the findings that 1) the effects of the androgens could not be reproduced by E2 administration, 2) nonaromatizable androgen dihydrotestosterone was as effective as aromatizable androgens, and 3) aromatase inhibitor did not prevent the action of the androgens to stimulate the P4 release. The effect of the androgens on the P4 release was rapid, occurring within 15 min of hormone administration. It was not prevented by inhibitors of protein and RNA synthesis, and the intracellular androgen receptor antagonist hydroxyflutamide did not affect the androgen action. Therefore, the androgen effects were not mediated through the intracellular androgen receptor and de novo protein synthesis was not needed for androgen-stimulated P4 release.
This article has been cited by other articles:
 |
|
 |
|
  C. Lopez-Garcia, A. J. Lopez-Contreras, A. Cremades, M. T. Castells, F. Marin, F. Schreiber, and R. Penafiel Molecular and Morphological Changes in Placenta and Embryo Development Associated with the Inhibition of Polyamine Synthesis during Midpregnancy in Mice Endocrinology, October 1, 2008; 149(10): 5012 - 5023. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Stocco, C. Telleria, and G. Gibori The Molecular Control of Corpus Luteum Formation, Function, and Regression Endocr. Rev., February 1, 2007; 28(1): 117 - 149. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P W Harvey, D J Everett, and C J Springall Hyperprolactinaemia as an adverse effect in regulatory and clinical toxicology: role in breast and prostate cancer Human and Experimental Toxicology, July 1, 2006; 25(7): 395 - 404. [Abstract] [PDF]
|
|
|
|
 |
|
 M Casais, S M Delgado, Z Sosa, and A M Rastrilla Pregnancy in rats is modulated by ganglionic cholinergic action. Reproduction, June 1, 2006; 131(6): 1151 - 1158. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Casais, S. M. Delgado, Z. Sosa, and A. M. Rastrilla Involvement of the coeliac ganglion in the luteotrophic effect of androstenedione in late pregnant rats Reproduction, February 1, 2006; 131(2): 361 - 368. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Kumazawa, K. Kawamura, T. Sato, N. Sato, Y. Konishi, Y. Shimizu, J. Fukuda, H. Kodoma, and T. Tanaka HCG up-regulates survivin mRNA in human granulosa cells Mol. Hum. Reprod., March 1, 2005; 11(3): 161 - 166. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. A. Goyeneche, V. Calvo, G. Gibori, and C. M. Telleria Androstenedione Interferes in Luteal Regression by Inhibiting Apoptosis and Stimulating Progesterone Production Biol Reprod, May 1, 2002; 66(5): 1540 - 1547. [Abstract] [Full Text]
|
|
|
|
|
|
D. J. Toft and D. I.H. Linzer Identification of Three Prolactin-Related Hormones as Markers of Invasive Trophoblasts in the Rat Biol Reprod, August 1, 2000; 63(2): 519 - 525. [Abstract] [Full Text]
|
|
|
|
|
|
S. Takiguchi, N. Sugino, S. Kashida, Y. Yamagata, Y. Nakamura, and H. Kato Rescue of the Corpus Luteum and an Increase in Luteal Superoxide Dismutase Expression Induced by Placental Luteotropins in the Rat: Action of Testosterone Without Conversion to Estrogen Biol Reprod, February 1, 2000; 62(2): 398 - 403. [Abstract] [Full Text]
|
|
|
|
|
|
D. J. Toft and D. I. H. Linzer Prolactin (PRL)-Like Protein J, a Novel Member of the PRL/Growth Hormone Family, Is Exclusively Expressed in Maternal Decidua Endocrinology, November 1, 1999; 140(11): 5095 - 5101. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
